塩野義製薬、米国のバイオ医薬品企業を買収へ 3155億円で
We haven't written up this one. Asahi Business has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- 塩野義製薬、米国のバイオ医薬品企業を買収へ 3155億円で asahi.com
More in Business
Build Canada Homes was launched a year ago. Can it scale up fast enough to meet demand?
Build Canada Homes promises to scale up the delivery of affordable housing at a time when industry leaders are raising the alarm about the lagging pace of housing development across the country.
Why I ditched potatoes for tree tomato fruits
Josphat Kipkurui turned half an acre into a Sh600,000 yearly harvest.
Power and price cuts applied to Volvo XC60 and XC90 T8 ranges
Latest updates only apply to the plug-in hybrid T8 models and not the mild-hybrid B5 variants.
Hong Kong lawmakers say 5-year tax incentive too short to entice major innovative firms
Hong Kong lawmakers have backed the government’s proposed tax incentives for large innovative companies, but many said on Monday that the planned five-year concession period is too short to attract major firms to establish headquarters or expand operations in the city.
Hong Kong lawmakers say 5-year tax incentive too short to entice major innovative firms
Hong Kong lawmakers have backed the government’s proposed tax incentives for large innovative companies, but many said on Monday that the planned five-year concession period is too short to attract major firms to establish headquarters or expand operations in the city.
People Moves: Texas Mutual Names Grube as VP of Austin Operations
Texas Mutual Insurance Company recently promoted John Grube to vice president of regional operations for Texas Mutual’s Austin region, effective May 2026. In this new role, Grube will direct and coordinate all regional office operations, including underwriting, claims, safety services, …